Sie sind auf Seite 1von 2

Proven | Non-Invasive | Drug-Free | Healthcare Solutions

Everyday, 40
Americans die from
prescription painkiller
abuse, the CDC says.
Overdoses of opioid prescription drugs now kill
more people in the U.S. than do overdoses from
heroin and cocaine combinedSource WebMD

A new
weapon to
effectively
treat pain
without
harmful
side effects.

Stop the pain


without harmful
side effects.

About the Manufacturer: Erchonia is the global leader in low level laser
healthcare applications. Over the last 16 years Erchonia has been conducting
research & development with the worlds leading physicians to advance the
science of low level lasers. Prior to market introductions, all Erchonia lasers
are proven to be safe and effective through level (1) independent clinical trials.
Currently thousands of Erchonia lasers are used daily to contour the waist,
hips, thighs and arms, treat chronic neck and shoulder pain, adjunct to pre and
post liposuction, pain associated with breast augmentation, treat acne and
treat cellulite. For additional information, visit www. erchonia.com All rights
reserved. 2013 Erchonia Corporation.

www.erchonia.com

888.242.0571 Toll Free


LASER RADIATION
DO NOT STARE INTO BEAM
CLASS 2 LASER

or 214.544.2227

IEC 60825-1:2001
<5mW 635nm
<5mW 405nm

Complies with 21 CFR 1040,10 and 1040,11


except for deviations pursuant to
Laser Notice No. 50, dated July 26, 2001
BST-405

LASER RADIATION
DO NOT STARE INTO BEAM
CLASS 2 LASER

635nm 7.50 1.00mW


IEC 60825-1:2001

LASER RADIATION
DO NOT STARE INTO BEAM
CLASS 2 LASER

IEC 60825-1:2001
<5mW 635nm
<5mW 405nm

Complies with 21 CFR 1040,10 and 1040,11


except for deviations pursuant to
Laser Notice No. 50, dated July 26, 2001

Complies with 21 CFR 1040,10 and 1040,11


except for deviations pursuant to
Laser Notice No. 50, dated July 26, 2001
HLS

BST-405

LASER RADIATION
DO NOT STARE INTO BEAM
CLASS 2 LASER

LASER RADIATION
DO NOT STARE INTO BEAM
CLASS 2 LASER

IEC 60825-1:2001
<5mW 635nm

Complies with 21 CFR 1040,10 and 1040,11


except for deviations pursuant to
Laser Notice No. 50, dated July 26, 2001
BST-635b

LASER RADIATION
DO NOT STARE INTO BEAM
CLASS 2 LASER

US PAT 6,013,096; US PAT 6,746,473


IEC 60825-1:2001
60825-1:2001
For additional US andIEC<5mW
International
patents
and patent pending
635nm 7.50 1.00mW
635nm
information go to www.erchonia.com
Complies with 21 CFR 1040,10 and 1040,11
except for deviations pursuant to
Laser Notice No. 50, dated July 26, 2001

BST-635b

LASER RADIATION
DO NOT STARE INTO BEAM
CLASS 2 LASER

IEC 60825-1:2001
635nm 7.50 1.00mW

Complies with 21 CFR 1040,10 and 1040,11


except for deviations pursuant to
Laser Notice No. 50, dated July 26, 2001

BST-635a

Patient_2014 Rev_4

Now there is a NEW


revolutionary treatment
that has been proven
safe and effective
by the FDA.
Welcome to the Erchonia line of handheld low level lasers:
XLR8, PL5000, PL Touch and Base Station

In the United States it is estimated that 56 million


individuals suffer from some form of chronic pain
annually. The prevalence of chronic pain accounts for
the greatest number of work absenteeism than any
other group of diseases, and the prevalence of chronic
pain reports is estimated to increase. Often, people
with acute or chronic pain (low back pain, a sore knee,
or persistent neck stiffness) will quickly turn to overthe-counter pain medicine for relief; however, the FDA
recently issued strict warnings regarding the misuse
and overdosing of over-the-counter pain medications
due to severe complications such as stomach ulcers,
hearing disorders and liver failure. Further, a growing
concern amongst physicians exists regarding the sideeffects associated with prescription pain medication.

Ask your doctor about the


benefits of low level lasers and
learn how the Erchonia laser
can work to treat pain...
The answers are simpler than
you might think.

Low level laser therapy (LLLT) or cold laser, is a


painless, sterile, non-invasive, drug-free modality that
is used for a variety of conditions such as, acute and
chronic pain, body-contouring, acne and cellulite.
Housed within the mitochondria, the cell energy
manufacturer, are receptors capable of absorbing
distinct parameters of light. Think of these receptors
like any drug receptors. When we consume a
prescription medication, the compound is absorbed
by the body and it locates a particular receptor, and
based upon its molecular design, will bind to that
receptor. Once the drug binds, a secondary reaction
inside the cell takes place. A similar mechanism is
observed when exposing the body to a particular
color of light. During a laser treatment the light will
penetrate the skin and is absorbed by this receptor
within the mitochondria. Receptor stimulation with
light promotes energy production, biochemical
reactions, protein and growth factor synthesis, cell
growth and proliferation and enhanced blood and
oxygen flow.

Increased blood flow reduces


inflammation that can cause pain.

www.erchonia.com

888.242.0571 Toll Free

LASER

Prevalence of chronic
pain in the US.

How does it work?

or 214.544.2227

SPINE

INFLAMMATION
CAUSING PAIN

SPINE

SPINE

LASER RADIATION
ACTIVATES CELLS

REDUCED
INFLAMMATION

Das könnte Ihnen auch gefallen